Los puntos clave no están disponibles para este artículo en este momento.
In the two European Union (EU)-funded projects, PCM4EU (Personalized Cancer Medicine for all EU citizens) and PRIME-ROSE (Precision Cancer Medicine Repurposing System Using Pragmatic Clinical Trials), we aim to facilitate implementation of precision cancer medicine (PCM) in Europe by leveraging the experience from ongoing national initiatives that have already been particularly successful.
Taskén et al. (Thu,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: